Granger’s NGS Testing coming up “Aces”

Granger Genetics presented the results from a recently completed studies at the Fall 2016 Symposium on Advanced Wound Care held this month at Caesar’s Palace in Las Vegas, NV. Dr. William Budd, Vice-President of Science and Technology for Granger Genetics presented an abstract entitled “Use of Molecular Identification to Determine Organisms in Wounds.” According to Dr. Budd, this work was well received and the community of wound care providers are excited at the coming molecular revolution. Medical providers understand the importance in unraveling the components involved in wound infections. Current processes are inadequate and fail to identify a large number of clinically relevant infections due to the inability of organisms to grow in culture. The study presented by the team from Granger Genetics used a next generation sequencing platform to identify organisms in patients exhibiting clinical symptoms of wound infection. The study showed that an infected wound contains over six distinct bacterial species, while uninfected wounds only have one dominant organism detected. It is important for clinicians to understand all organisms involved in an infection as it is the interactions of these organisms that cause the development of biofilms and leads to impaired wound healing. This work highlights the need for more comprehensive diagnostic testing in the wound care field.